{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:40:21Z","timestamp":1760924421545,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.biologicals.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T16:03:29Z","timestamp":1642435409000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats"],"prefix":"10.1016","volume":"75","author":[{"given":"Yan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-7863","authenticated-orcid":false,"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingbo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2022.01.005_bib1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1473-3099(20)30555-7","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial","volume":"21","author":"Bandyopadhyay","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biologicals.2022.01.005_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2022.01.005_bib3","unstructured":"WHO-UNICEF. Supply of IPV and OPV:current status and looking forward. 18th WHO-UNICEF Consultation with OPV\/IPV Manufactures,National Authorities for Containment and National Regulatory Authorities2019."},{"key":"10.1016\/j.biologicals.2022.01.005_bib4","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/infdis\/jix038","article-title":"Intradermal administration of fractional doses of inactivated poliovirus vaccine: a dose-sparing option for polio immunization","volume":"216","author":"Okayasu","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2022.01.005_bib5","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.vaccine.2012.12.076","article-title":"Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains","volume":"31","author":"Westdijk","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.01.005_bib6","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2020.02.066","article-title":"Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months","volume":"38","author":"S\u00e1ez-Llorens","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.01.005_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1542\/peds.12.5.471","article-title":"Recent studies on immunization against poliomyelitis","volume":"12","author":"Salk","year":"1953","journal-title":"Pediatrics"},{"key":"10.1016\/j.biologicals.2022.01.005_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0140-6736(91)90480-D","article-title":"Immune response to intradermally injected inactivated poliovirus vaccine","volume":"338","author":"Samuel","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2022.01.005_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0264-410X(92)90039-M","article-title":"Immune response of infants to inactivated poliovirus vaccine injected intradermally","volume":"10","author":"Samuel","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.01.005_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2471\/BLT.18.218370","article-title":"Fractional-dose inactivated poliovirus vaccine, India","volume":"97","author":"Haldar","year":"2019","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2022.01.005_bib11","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/j.vaccine.2014.03.024","article-title":"Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same?","volume":"32","author":"Levin","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.01.005_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0035-9203(99)90309-7","article-title":"Immunogenicity and safety of low-dose intradermal rabies vaccination given during an Expanded Programme on immunization session in Viet Nam: results of a comparative randomized trial","volume":"93","author":"Lang","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2022.01.005_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2019.08.005","article-title":"Preparation of H1N1 microneedles by a low-temperature process without a stabilizer","volume":"143","author":"Jeong","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"volume":"vol. 7","year":"2019","author":"Muller","key":"10.1016\/j.biologicals.2022.01.005_bib14"},{"key":"10.1016\/j.biologicals.2022.01.005_bib15","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1016\/j.vaccine.2019.08.036","article-title":"Skin immunization with third-generation hepatitis B surface antigen using microneedles","volume":"37","author":"Nguyen","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.01.005_bib16","first-page":"9251","volume":"vol. 9","author":"Christiansen","year":"2019"},{"key":"10.1016\/j.biologicals.2022.01.005_bib17","first-page":"630","volume":"vol. 24","author":"Ogai","year":"2018"},{"key":"10.1016\/j.biologicals.2022.01.005_bib18","doi-asserted-by":"crossref","first-page":"100032","DOI":"10.1016\/j.jvacx.2019.100032","article-title":"Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine","volume":"2","author":"Mvundura","year":"2019","journal-title":"Vaccine X"},{"key":"10.1016\/j.biologicals.2022.01.005_bib19","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/infdis\/jiu624","article-title":"Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study","volume":"211","author":"Kouiavskaia","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2022.01.005_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1473-3099(17)30177-9","volume":"17","author":"Rivera","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biologicals.2022.01.005_bib21","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.vaccine.2019.10.064","article-title":"Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: a phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age","volume":"38","author":"Bravo","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.01.005_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jmv.25298","article-title":"An adjuvant compound that enhances immunogenicity at fractional doses of the Sabin-inactivated poliovirus vaccine (sIPV) with a long duration of protection in a rat model","volume":"91","author":"Song","year":"2019","journal-title":"J Med Virol"},{"key":"10.1016\/j.biologicals.2022.01.005_bib23","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/infdis\/jiw433","article-title":"Phase 3 trial of a Sabin strain-based inactivated poliovirus vaccine","volume":"214","author":"Liao","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2022.01.005_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2010.05.012","article-title":"Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat","volume":"149","author":"Matsuo","year":"2011","journal-title":"J Contr Release"},{"key":"10.1016\/j.biologicals.2022.01.005_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/mnfr.200700396","article-title":"Influence of a cocoa-enriched diet on specific immune response in ovalbumin-sensitized rats","volume":"53","author":"Perez-Berezo","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.biologicals.2022.01.005_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2016.07.055","article-title":"Repeated fractional intradermal dosing of an inactivated polio vaccine by a single hollow microneedle leads to superior immune responses","volume":"242","author":"Schipper","year":"2016","journal-title":"J Contr Release"},{"key":"10.1016\/j.biologicals.2022.01.005_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4067\/S0716-10182019000100083","article-title":"Remarks on the possibility of introducing the fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule","volume":"36","author":"Arbo","year":"2019","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.biologicals.2022.01.005_bib28","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/S0140-6736(19)30503-3","article-title":"Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial","volume":"393","author":"Snider","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2022.01.005_bib29","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1016\/j.vaccine.2015.06.071","article-title":"Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: association between injection quality and immunogenicity","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2022.01.005_bib30","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/infdis\/jiu841","article-title":"Comparison of the immunogenicity of various booster doses of inactivated polio vaccine delivered intradermally versus intramuscularly to HIV-infected adults","volume":"211","author":"Troy","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2022.01.005_bib31","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1080\/21645515.2016.1214347","article-title":"Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats","volume":"12","author":"Ma","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2022.01.005_bib32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4161\/hv.7.8.16274","article-title":"Transcutaneous and intradermal vaccination","volume":"7","author":"Combadiere","year":"2011","journal-title":"Hum Vaccine"},{"volume":"vol. 14","year":"2019","author":"Oreskovic","key":"10.1016\/j.biologicals.2022.01.005_bib33"},{"key":"10.1016\/j.biologicals.2022.01.005_bib34","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1128\/jvi.70.9.6119-6125.1996","article-title":"Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery","volume":"70","author":"Pertmer","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2022.01.005_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2022.01.005_bib36","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.biologicals.2022.01.005_bib37","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1093\/infdis\/jiu128","article-title":"Affordable inactivated poliovirus vaccine: strategies and progress","volume":"210","author":"Okayasu","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2022.01.005_bib38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame","volume":"3","author":"Estivariz","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.biologicals.2022.01.005_bib39","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2022.01.005_bib40","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105622000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105622000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:15:16Z","timestamp":1760922916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105622000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":40,"alternative-id":["S1045105622000057"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2022.01.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"type":"print","value":"1045-1056"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}